Maryland Statutes
Subtitle 33 - Natalie M. Laprade Medical Cannabis Commission
Section 13-3305.2 - Study of Market With Respect to Assistance of Minorities and Women in Medical Cannabis Industry

(a)    The Commission, in consultation with the certification agency as defined in § 14–301 of the State Finance and Procurement Article, the Governor’s Office of Small, Minority, and Women Business Affairs, and the Office of the Attorney General, shall:
        (1)    Evaluate a study of the medical cannabis industry and market to determine whether there is a compelling interest to implement remedial measures, including the application of the State Minority Business Enterprise Program under Title 14, Subtitle 3 of the State Finance and Procurement Article or a similar program, to assist minorities and women in the medical cannabis industry;
        (2)    Evaluate race–neutral programs or other methods that may be used to address the needs of minority and women applicants and minority and women–owned businesses seeking to participate in the medical cannabis industry; and
        (3)    Submit emergency regulations, in accordance with Title 10, Subtitle 1 of the State Government Article, to implement remedial measures, if necessary and to the extent permitted by State and federal law, based on the findings of the study evaluated under item (1) of this subsection.
    (b)    The Commission may report to the General Assembly, in accordance with § 2–1257 of the State Government Article, any information that the Commission determines to be necessary to the consideration, development, or implementation of any remedial measures required under this section.

Structure Maryland Statutes